Literature DB >> 26902292

Temporal and spatial distribution of macrophage phenotype markers in the foreign body response to glutaraldehyde-crosslinked gelatin hydrogels.

Tony Yu1, Wenbo Wang2, Sina Nassiri1, Thomas Kwan3, Chau Dang1, Wei Liu2, Kara L Spiller1.   

Abstract

Currently, it is not well understood how changes in biomaterial properties affect the foreign body response (FBR) or macrophage behavior. Because failed attempts at biomaterial degradation by macrophages have been linked to frustrated phagocytosis, a defining feature of the FBR, we hypothesized that increased hydrogel crosslinking density (and decreased degradability) would exacerbate the FBR. Gelatin hydrogels were crosslinked with glutaraldehyde (0.05, 0.1, and 0.3%) and implanted subcutaneously in C57BL/6 mice over the course of 3 weeks. Interestingly, changes in hydrogel crosslinking did not affect the thickness of the fibrous capsule surrounding the hydrogels, expression of the pan-macrophage marker F480, expression of three macrophage phenotype markers (iNOS, Arg1, CD163), or expression of the myofibroblast marker aSMA, determined using semi-quantitative immunohistochemical analysis. With respect to temporal changes, the level of expression of the M1 marker (iNOS) remained relatively constant throughout the study, while the M2 markers Arg1 and CD163 increased over time. Expression of these M2 markers was highly correlated with fibrous capsule thickness. Differences in spatial distribution of staining also were noted, with the strongest staining for iNOS at the hydrogel surface and increasing expression of the myofibroblast marker aSMA toward the outer edge of the fibrous capsule. These results confirm previous reports that macrophages in the FBR exhibit characteristics of both M1 and M2 phenotypes. Understanding the effects (or lack of effects) of biomaterial properties on the FBR and macrophage phenotype may aid in the rational design of biomaterials to integrate with surrounding tissue.

Entities:  

Keywords:  Foreign body response; gelatin hydrogel; glutaraldehyde crosslinking; macrophage phenotype

Mesh:

Substances:

Year:  2016        PMID: 26902292      PMCID: PMC4879875          DOI: 10.1080/09205063.2016.1155881

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  67 in total

1.  In vivo biocompatibility of gelatin-based hydrogels and interpenetrating networks.

Authors:  Kelly R Stevens; Nicole J Einerson; Jeanine A Burmania; Weiyuan John Kao
Journal:  J Biomater Sci Polym Ed       Date:  2002       Impact factor: 3.517

2.  Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate.

Authors:  Stefan Rammelt; Till Illert; Susanne Bierbaum; Dieter Scharnweber; Hans Zwipp; Wolfgang Schneiders
Journal:  Biomaterials       Date:  2006-08-01       Impact factor: 12.479

3.  IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.

Authors:  Stefan Fichtner-Feigl; Warren Strober; Koji Kawakami; Raj K Puri; Atsushi Kitani
Journal:  Nat Med       Date:  2005-12-04       Impact factor: 53.440

4.  Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection.

Authors:  Rizwan A Manji; Lin F Zhu; Nimrit K Nijjar; David C Rayner; Greg S Korbutt; Thomas A Churchill; Ray V Rajotte; Arvind Koshal; David B Ross
Journal:  Circulation       Date:  2006-07-10       Impact factor: 29.690

5.  M-1/M-2 macrophages and the Th1/Th2 paradigm.

Authors:  C D Mills; K Kincaid; J M Alt; M J Heilman; A M Hill
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

Review 6.  Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking.

Authors:  Isabelle Migneault; Catherine Dartiguenave; Michel J Bertrand; Karen C Waldron
Journal:  Biotechniques       Date:  2004-11       Impact factor: 1.993

7.  Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects.

Authors:  P Quinten Ruhé; Elizabeth L Hedberg-Dirk; Nestor Torio Padron; Paul H M Spauwen; John A Jansen; Antonios G Mikos
Journal:  Tissue Eng       Date:  2006-04

8.  Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages.

Authors:  A Gratchev; J Kzhyshkowska; J Utikal; S Goerdt
Journal:  Scand J Immunol       Date:  2005-01       Impact factor: 3.487

9.  In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels.

Authors:  Heungsoo Shin; P Quinten Ruhé; Antonios G Mikos; John A Jansen
Journal:  Biomaterials       Date:  2003-08       Impact factor: 12.479

10.  Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease.

Authors:  Y Wang; Y P Wang; G Zheng; V W S Lee; L Ouyang; D H H Chang; D Mahajan; J Coombs; Y M Wang; S I Alexander; D C H Harris
Journal:  Kidney Int       Date:  2007-04-18       Impact factor: 10.612

View more
  23 in total

1.  Injectable porcine bone demineralized and digested extracellular matrix-PEGDA hydrogel blend for bone regeneration.

Authors:  Fabian Obregon-Miano; Ali Fathi; Catherine Rathsam; Isbel Sandoval; Fariba Deheghani; Axel Spahr
Journal:  J Mater Sci Mater Med       Date:  2020-01-27       Impact factor: 3.896

Review 2.  Extracellular Matrix-Based Strategies for Immunomodulatory Biomaterials Engineering.

Authors:  Andrew T Rowley; Raji R Nagalla; Szu-Wen Wang; Wendy F Liu
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

Review 3.  Macrophage-based therapeutic strategies in regenerative medicine.

Authors:  Kara L Spiller; Timothy J Koh
Journal:  Adv Drug Deliv Rev       Date:  2017-05-16       Impact factor: 15.470

4.  Inflammation via myeloid differentiation primary response gene 88 signaling mediates the fibrotic response to implantable synthetic poly(ethylene glycol) hydrogels.

Authors:  Luke D Amer; Leila S Saleh; Cierra Walker; Stacey Thomas; William J Janssen; Scott Alper; Stephanie J Bryant
Journal:  Acta Biomater       Date:  2019-09-27       Impact factor: 8.947

Review 5.  Drug delivery strategies to control macrophages for tissue repair and regeneration.

Authors:  Reham Garash; Anamika Bajpai; Brandon M Marcinkiewicz; Kara L Spiller
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-06

6.  Distinct release strategies are required to modulate macrophage phenotype in young versus aged animals.

Authors:  Daniel Hachim; Aimon Iftikhar; Samuel T LoPresti; Alexis L Nolfi; Shweta Ravichandar; Clint D Skillen; Bryan N Brown
Journal:  J Control Release       Date:  2019-05-17       Impact factor: 9.776

Review 7.  Sequential drug delivery to modulate macrophage behavior and enhance implant integration.

Authors:  Erin M O'Brien; Gregory E Risser; Kara L Spiller
Journal:  Adv Drug Deliv Rev       Date:  2019-05-16       Impact factor: 15.470

8.  Anti-inflammatory effects of octadecylamine-functionalized nanodiamond on primary human macrophages.

Authors:  A E Pentecost; C E Witherel; Y Gogotsi; K L Spiller
Journal:  Biomater Sci       Date:  2017-09-26       Impact factor: 6.843

Review 9.  Macrophage and Fibroblast Interactions in Biomaterial-Mediated Fibrosis.

Authors:  Claire E Witherel; Daniel Abebayehu; Thomas H Barker; Kara L Spiller
Journal:  Adv Healthc Mater       Date:  2019-01-18       Impact factor: 9.933

10.  Chronic Granulomatous Inflammation after CyPass® Implantation.

Authors:  Kristina Joana Schoelles; Alexandra Anton; Claudia Auw-Haedrich
Journal:  Ocul Oncol Pathol       Date:  2020-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.